Half-year report · HY
4885.TEDINET S100XFQT
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2025-06-01 → 2025-11-30 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2024-06-01 → 2024-11-30 | Standalone | Net sales |
| Operating income | ¥349m | 2025-06-01 → 2025-11-30 | Standalone | Operating income |
| Operating income | ¥154m | 2024-06-01 → 2024-11-30 | Standalone | Operating income |
| Ordinary income | ¥337m | 2025-06-01 → 2025-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥430m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Ordinary income |
| Profit before tax | ¥336m | 2025-06-01 → 2025-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥171m | 2024-06-01 → 2024-11-30 | Standalone | Income before income taxes |
| Net income | ¥244m | 2025-06-01 → 2025-11-30 | Standalone | Profit loss |
| Net income | ¥241m | 2024-06-01 → 2025-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥121m | 2024-06-01 → 2024-11-30 | Standalone | Profit loss |
| Total assets | ¥6.5bn | at 2025-11-30 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥5.5bn | at 2024-11-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.8bn | at 2025-11-30 | Standalone | Liabilities |
| Total liabilities | ¥2.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.7bn | at 2025-11-30 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.3bn | at 2024-11-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2025-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.8bn | at 2025-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2025-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2024-11-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-05-31v | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥282m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥216m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥137m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥141m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥371m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥188m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥672m | 2025-06-01 → 2025-11-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥123m | 2024-06-01 → 2025-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥336m | 2024-06-01 → 2024-11-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥60.85 | 2025-06-01 → 2025-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.42 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.29 | 2024-06-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥59.98 | 2025-06-01 → 2025-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.49 | 2024-06-01 → 2025-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.82 | 2024-06-01 → 2024-11-30 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2025-06-01 → 2025-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 41.0% | at 2025-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.6% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2025-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Products Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥1.3bn |
| Chemical Products Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥1.3bn |
| Chemical Products Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥58m |
| Healthy Food Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥660m |
| Healthy Food Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥660m |
| Healthy Food Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥6m |
| Pharmaceutical Businessreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥1.8bn |
| Pharmaceutical Businessreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥1.8bn |
| Pharmaceutical Businessreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥285m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥3.7bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥3.7bn |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥349m |
| Chemical Products Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| Chemical Products Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| Chemical Products Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥17m |
| Healthy Food Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥523m |
| Healthy Food Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥523m |
| Healthy Food Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥5m |
| Pharmaceutical Businessreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| Pharmaceutical Businessreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥1.4bn |
| Pharmaceutical Businessreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥167m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥3.0bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥154m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes receivable trade | InterimInstant_NonConsolidatedMember | 20968000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant_NonConsolidatedMember | 178058000 | JPY |
| Electronically recorded monetary claims operating ca | InterimInstant_NonConsolidatedMember | 398347000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 1092802000 | JPY |
| Accounts receivable trade | InterimInstant_NonConsolidatedMember | 988200000 | JPY |
| Contract assets | Prior1YearInstant_NonConsolidatedMember | 21000 | JPY |
| Contract assets | InterimInstant_NonConsolidatedMember | 7297000 | JPY |
| Merchandise and finished goods | Prior1YearInstant_NonConsolidatedMember | 557227000 | JPY |
| Merchandise and finished goods | InterimInstant_NonConsolidatedMember | 831480000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 129239000 | JPY |
| Work in process | InterimInstant_NonConsolidatedMember | 88476000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 392197000 | JPY |
| Raw materials and supplies | InterimInstant_NonConsolidatedMember | 449543000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 197628000 | JPY |
| Other ca | InterimInstant_NonConsolidatedMember | 114843000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 3608522000 | JPY |
| Current assets | InterimInstant_NonConsolidatedMember | 4775442000 | JPY |
| Buildings net | Prior1YearInstant_NonConsolidatedMember | 454906000 | JPY |
| Buildings net | InterimInstant_NonConsolidatedMember | 450928000 | JPY |
| Machinery and equipment net | Prior1YearInstant_NonConsolidatedMember | 230427000 | JPY |
| Machinery and equipment net | InterimInstant_NonConsolidatedMember | 257032000 | JPY |
| Land | Prior1YearInstant_NonConsolidatedMember | 260431000 | JPY |
| Land | InterimInstant_NonConsolidatedMember | 260431000 | JPY |
| Other net ppe | Prior1YearInstant_NonConsolidatedMember | 162940000 | JPY |
| Other net ppe | InterimInstant_NonConsolidatedMember | 144626000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 1108705000 | JPY |
| Property plant and equipment | InterimInstant_NonConsolidatedMember | 1113018000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 53174000 | JPY |
| Intangible assets | InterimInstant_NonConsolidatedMember | 47484000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 301431000 | JPY |
| Investment securities | InterimInstant_NonConsolidatedMember | 360174000 | JPY |
| Deferred tax assets | Prior1YearInstant_NonConsolidatedMember | 107461000 | JPY |
| Deferred tax assets | InterimInstant_NonConsolidatedMember | 79620000 | JPY |
| Other ioa | Prior1YearInstant_NonConsolidatedMember | 85278000 | JPY |
| Other ioa | InterimInstant_NonConsolidatedMember | 94095000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 494171000 | JPY |
| Investments and other assets | InterimInstant_NonConsolidatedMember | 533890000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 1656051000 | JPY |
| Noncurrent assets | InterimInstant_NonConsolidatedMember | 1694393000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 5264574000 | JPY |
| Assets | InterimInstant_NonConsolidatedMember | 6469836000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 351022000 | JPY |
| Accounts payable trade | InterimInstant_NonConsolidatedMember | 682626000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant_NonConsolidatedMember | 403504000 | JPY |
| Current portion of long term loans payable | InterimInstant_NonConsolidatedMember | 650006000 | JPY |
| Income taxes payable | Prior1YearInstant_NonConsolidatedMember | 96481000 | JPY |
| Income taxes payable | InterimInstant_NonConsolidatedMember | 84940000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 207286000 | JPY |
| Provision for bonuses | InterimInstant_NonConsolidatedMember | 216192000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 397039000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |